Apr 15, 2026
This episode features Neil Tween, CFO of Owlstone Medical, and his path from audit at Deloitte into biotech and life sciences.
He started in accounting, which gave him a strong foundation in public company reporting and SEC requirements. But what really pulled him was the science side and working on “novel...